A large family of UDP-GalNAc:polypeptide GalNAc transferases (ppGalNAc-Ts) initiates and defines sites of mucin-type Ser/Thr-O-GalNAc glycosylation. Family members have been classified into peptide-and glycopeptide-preferring subfamilies, although both families possess variable activities against glycopeptide substrates. All but one isoform contains a C-terminal carbohydrate-binding lectin domain whose roles in modulating glycopeptide specificity is just being understood. We have previously shown for several peptide-preferring isoforms that the presence of a remote Thr-O-GalNAc, 6-17 residues from a Ser/Thr acceptor site, may enhance overall catalytic activity in an N-or C-terminal direction. This enhancement varies with isoform and is attributed to Thr-O-GalNAc interactions at the lectin domain. We now report on the glycopeptide substrate utilization of a series of glycopeptide (human-ppGalNAc-T4, T7, T10, T12 and fly PGANT7) and peptide-preferring transferases (T2, T3 and T5) by exploiting a series of random glycopeptide substrates designed to probe the functions of their catalytic and lectin domains. Glycosylation was observed at the −3, −1 and +1 residues relative to a neighboring Thr-O-GalNAc, depending on isoform, which we attribute to specific Thr-O-GalNAc binding at the catalytic domain. Additionally, these glycopeptide-preferring isoforms show remote lectin domain-assisted Thr-O-GalNAc enhancements that vary from modest to none. We conclude that the glycopeptide specificity of the glycopeptide-preferring isoforms predominantly resides in their catalytic domain but may be further modulated by remote lectin domain interactions. These studies further demonstrate that both domains of the ppGalNAc-Ts have specialized and unique functions that work in concert to control and order mucin-type O-glycosylation.
Introduction
Mucin-type protein O-glycosylation is a common and essential posttranslational modification in higher organisms that begins with the transfer of the sugar N-acetylgalactosamine (GalNAc) onto the hydroxyl groups of Ser or Thr residues of protein substrates. This type of protein glycosylation is initiated in the Golgi complex by a large family of enzymes known as the UDP-GalNAc:polypeptide N-α-acetylgalactosaminyl-transferases ( ppGalNAc-T's). These enzymes therefore define the sites of O-glycosylation.
Mucin-type O-glycosylation is critical for development, where in the fly, several ppGalNAc-T (PGANT) isoforms are essential for viability (Ten Hagen and Tran 2002; Tran and Ten Hagen 2013; Zhang et al. 2014) , cell adhesion, and proper secretory apparatus function (Zhang et al. 2014 ). In addition, O-glycosylation of cell surface receptors may be regulated by specific ppGalNAc-T isoforms that appear to modulate receptor signaling Semenov et al. 2009; Schjoldager et al. 2010 ). In the mouse, ppGalNAc-T1 modulates salivary gland organogenesis (Tian et al. 2012) and is required for proper heart and valve development (Tian et al. 2015) . Inactivating mutations in ppGalNAc-T3 are responsible for the human disease familial tumoral calcinosis, which is characterized by defects in phosphate regulation. This is the first human disease linked to a specific ppGalNAc-T and is mechanistically caused by the loss of the specific glycosylation of the phosphaturic factor, FGF23, which leads to its proteolytic cleavage . Such modulation of protease cleavage sites may be a common function for O-glycosylation in biology (Semenov et al. 2009; Schjoldager et al. 2010) . Finally, genome wide association studies have identified a number of distinct ppGalNAc-T isoforms that are associated with certain human diseases and conditions (Simmons et al. 1999; Topaz et al. 2004; Kathiresan et al. 2008; Willer et al. 2008; Holleboom et al. 2011; Nakayama et al. 2012; Miyazaki et al. 2013; Takasaki et al. 2014) , including many cancers (Kohsaki et al. 2000; Berois et al. 2006; Brockhausen 2006; Wood et al. 2007; Libisch et al. 2014) . Altogether, these studies indicate essential (but not well understood) roles for this type of protein modification across diverse tissues and species.
Members of the ppGalNAc-T family (20 different isoforms in man) have been classified into two major families (I and II) based on their peptide/glycopeptide preferences, respectively. Although this distinction has been historically used, some overlap in substrate preferences exists among transferase isoforms. The families have been further divided into subfamilies (Ia-g and IIa-b, Figure 1A ) based on their amino acid sequence similarities which tend to correlate with their overall peptide/glycopeptide substrate preferences . Family I members readily glycosylate peptide substrates and have been termed "peptide-preferring" isoforms; however, several members of this family (Ia-d) have been shown to be influenced by remote, 6-17 residue, prior Ser/Thr-O-GalNAc glycosylation via utilization of their lectin domains (see Figure 1B and below) (Gerken et al. 2013) . Family IIa-b members on the other hand commonly display nearly sole activities against Ser/Thr-O-GalNAc containing glycopeptides and hence have been termed "glycopeptide-preferring" isoforms, although some isoforms ( particularly subfamily IIa) can also readily glycosylate unglycosylated peptide substrates (Hassan et al. 2000; Gerken et al. 2011) . Because of the increasingly complex peptide and glycopeptide specificities now being observed for these transferases, and taking in account the results of the present work, we will suggest below, a more precise reclassification of the ppGalNAc-T family. This takes in account our observations, that depending on the isoform, glycopeptides can interact with either the lectin or catalytic domains (or both) thereby resulting in significantly different glycopeptide specificities (see Figure 9 and Discussion).
Structurally, ppGalNAc-T family members (except h-ppGalNAc-T20) 1 (Raman et al. 2012) , consist of an N-terminal catalytic domain linked to a C-terminal ricin like lectin domain containing three potential carbohydrate Ser/Thr-O-GalNAc-binding sites ( Figure 1B ; Fritz et al. 2006; Kubota et al. 2006; Yoshimura et al. 2012) . Both domains are linked via a short flexible segment that varies in length among isoforms creating flexibility between domains (Fritz et al. 2004 Kubota et al. 2006; Lira-Navarrete et al. 2015) . How these domains modulate the peptide and glycopeptide activities of the different subfamilies is just being understood (Raman et al. 2008; Gerken et al. 2013; Lira-Navarrete et al. 2015) . We and others have shown that the ppGalNAc-T's display specific peptide substrate preferences that vary among isoforms (Perrine et al. 2009; Gerken et al. 2011) . This modulation of substrate specificity is based on peptide sequence, charge and importantly neighboring glycosylation. The placement of a Ser/Thr-O-GalNAc residue near a glycosylation site results in multiple effects. These effects vary from a relative inhibition of glycosylation to a requirement for a neighboring GalNAc, and may also include an alteration or shift in glycosylation site. Thus the family I "peptide-preferring" ppGalNAc-T2 utilizes its lectin domain for modulating directionality and site preference against Ser/Thr-O-GalNAc glycopeptides, while the family II "glycopeptidepreferring" ppGalNAc-T10 utilizes its catalytic domain for its near absolute requirement for a neighboring Ser/Thr-O-GalNAc (Kubota et al. 2006; Raman et al. 2008; Perrine et al. 2009 ).
Recently, we reported that the presence of a remote N-or C-terminal placed Thr-O-GalNAc can be an important determinant of overall catalytic activity and specificity in eight of the characterized transferases in "peptide-preferring" subfamilies Ia-Id which differed among isoforms (Gerken et al. 2013) . This N-or C-terminal selectivity is thought to be due to glycopeptide Ser/Thr-O-GalNAc binding to the lectin domain whose orientation may be highly dynamic and isoform dependent. We have previously proposed that this N-or C-directional specificity may serve to control the specificity of mucin-type O-glycosylation suggesting that O-glycosylation may actually be highly ordered (Gerken et al. 2013) .
Here, we address the roles of the catalytic and lectin domains of the "glycopeptide-preferring" transferases in subfamilies IIa ( ppGalNAc-T4 and T12) and IIb ( ppGalNAc-T7 and T10). Although both subfamilies will readily glycosylate Ser/Thr-O-GalNAc glycopeptides, they differ in their ability to readily glycosylate nonglycosylated peptide substrates (Bennett et al. 1998 (Bennett et al. ,1999 Raman et al. 2008; Perrine et al. 2009; Gerken et al. 2011; Raman et al. 2008; Perrine et al. 2009 ). Using our series of lectin and catalytic domain probing glycopeptide substrates, we are able to define the role of the lectin and catalytic domains in the recognition of extant GalNAc on glycopeptide substrates. Specifically, we have determined that members of these subfamilies prefer to add GalNAc in close proximity to a previously glycosylated residue (i.e. neighboring glycosylation), suggesting a mechanism whereby the catalytic domain preferentially recognizes an existing GalNAc in glycopeptide substrates. Comparative studies on the fly orthologue of ppGalNAc-T7, PGANT7, have also been performed further demonstrating conservation of these mechanistic specificities across species.
1 We will be using the transferase numbering system of Bennett et al. (2012) for consistency.
This work in conjunction with our prior studies will be highly useful for refining predictive approaches for identifying sites of mucin-type O-glycosylation that thus far have been limited by a lack of isoform-specific peptide and glycopeptide glycosylation data Hansen et al. 1998; Chen et al. 2008; Steentoft et al. 2013) .
Results

Design and use of (Glyco)peptide substrates
In previous studies (Perrine et al. 2009; Gerken et al. 2013) , we designed a series of random (glyco)peptide substrates to interrogate the roles of the lectin and catalytic domains in modulating glycopeptide specificity for several family I and one family II ppGalNAc-T's (Table I) . As described below, these were based on characterizing the effects of remote and neighboring prior Ser/Thr-O-GalNAc glycosylation, respectively, on transferase activity.
Lectin domain probing random glycopeptide substrates GP(T*22)R and GP(T*10)L (formerly named GPIV and GPV (Gerken et al. 2013 
))
These substrates address the modulating role of a remote Thr-O-GalNAc (abbreviated as T*) on transferase activity, based on the assumption that the T* would bind at the lectin domain. These substrates were designed to be sufficiently long (29 residues) to span the catalytic and lectin domains based on the crystal structures of ppGalNAc-T1 and T2 (Fritz et al. 2004  Figure 1B ). As shown in Table I , each acceptor substrate contained a T* placed near the C-or N-terminal (GP(T*22)R and GP(T*10)L, where R is for right and L for left placed T*, respectively) which in turn were flanked by five randomized Z residues lacking an acceptor Ser or Thr. An additional 12 randomized X residues, also including the acceptor Thr, were extended from the Z's in an N-or C-terminal direction, respectively. These X residues thus serve to probe glycosylation 6-17 residues from an existing T* in an N-or C-direction, respectively. To confirm that the T* in these glycopeptides are indeed interacting with the lectin domain, non-interacting control peptides were also used where the T* was replaced by an Ala residue (GP(A22)R and GP(A10)L, respectively). With these (glyco)peptides, we can determine the extent that remote Thr-O-GalNAc interactions, at the lectin domain can enhance catalytic domain glycosylation of the X residues and whether there is a preferred N-or C-directionality. (For clarity, results for the GP-R series of substrates will be presented in shades of red and those for GP-L will be in shades of blue.)
Confirmation that these lectin domain substrates indeed are reporting on lectin domain binding/interactions of a GalNAc residue was shown in our prior work (Gerken et al. 2013) . Furthermore, these substrates correctly report the observed remote T* lectin binding directionality for ppGalNAc-T2 and T3. Thus, ppGalNAc-T2, which prefers to bind a C-terminal T* based on its preference for GP (T*22)R (Gerken et al. 2013) , is shown bound to a C-terminal glycosylated MUC5AC-13 glycopeptide in a recently reported X-ray crystal structure (Lira-Navarrete et al. 2015). In addition, the kinetic studies Bennett et al. 2012) . "Peptide-preferring" transferases in subfamilies Ia-Ig (except Ie) are highlighted in red. The "glycopeptide-preferring" transferases (subfamilies IIa-IIb) are highlighted in blue. Note that subfamily Ie ("Y" series of transferases (Li et al. 2012) ) is highlighted in gray due to their largely unknown activities. (B) ppGalNAc-T2 crystal structure (PDP 2FFU) with EA2 peptide bound to the catalytic domain . The residues of EA2 ( Ser is blue; the C-terminal Lys is red; the Pro residues are purple and the remaining Thr are brown. In the lectin domain, the Asp 458 residue that is required for glycopeptide binding is space-filled in pink (Wandall et al. 2007; Pederson et al. 2011) . prefers an N-terminal T* based on its preference for GP(T*10)L and is known to sequentially glycosylate an FGF23 peptide at two sites that are seven residues apart in an N-to C-order (Gerken et al. 2013) . The glycosylation of the latter C-terminal site was shown to require a ppGalNAc-T3 possessing an active lectin domain, in agreement with its preference for GP(T*10)L (Gerken et al. 2013 ).
Catalytic domain probing random glycopeptide substrate GP(T*10)C
The design of GP(T*10)C is based on a substrate analog GPII that has been previously employed to characterize T* binding at the catalytic domain of ppGalNAc-T10 (Perrine et al. 2009 ). GP(T*10)C (where C is for a center placed T*) has the general form GA-GAXXXXXT*XXXXXAGAG where the random X residues flanking the central Thr-O-GalNAc contain unglycosylated Ser residues that can serve as an acceptor. Using this substrate, we can address the role of a single T* on the glycosylation of its directly neighboring residues, X, using UDP-[ Since the acceptor (X) regions of GP(T*10)C are directly flanking T*, the glycosylation of the closely neighboring sites of GP(T*10)C are unlikely to be modulated by T* binding at the lectin domain. Support for this conclusion is found in the recent modeling of a glycopeptide bound to the ppGalNAc-T2 lectin domain reported by Lira-Navarrete et al. (2015) . In their plot of predicted enzymatic activity vs. residue separation, no sites closer than 5 residues from the T* were predicted to be glycosylated by T2, while a broad peak of glycosylation was predicted between 7 and 14 residues from the T* (see Figure 5C of Lira-Navarrete et al. 2015) .
We have previously used a shortened version of GP(T*10)C (named GPII) to reveal a specific Thr-O-GalNAc recognition site on the catalytic domain of the "glycopeptide-preferring" ppGalNAc-T10 (Perrine et al. 2009 ). This site targets glycosylation directly N-terminal of a prior site of Ser/Thr-O-GalNAc glycosylation (Perrine et al. 2009 ). Prior work of Raman et al. (2008) has also confirmed such a site on ppGalNAc-T10. (For clarity, results with GP(T*10)C will be presented in green.) A nonglycosylated control peptide for GP(T*10) C where the center T*is replaced with Ala, GP(A10)C was also obtained and used against a subset of transferases (presented in yellow).
Glycosylation of the GP-L and GP-R series and GP(T*10) C glycopeptides
The results of the glycosylation of the lectin and catalytic domain probing substrates by one representative family I and five family II transferases are presented in Figures 2 and 3. In Figure 2 , plots of total UDP-[ H]-GalNAc (second-eluting peak). Our previous work on eight of the family I transferases (in subfamilies Ia-Id) demonstrated little hydrolysis of UDP-GalNAc when the lectin probing glycopeptides GP(T*22)R, GP(T*10)L and their controls were used in glycosylating reactions (Gerken et al. 2013) . As an example, plots for ppGalNAc-T5 (subfamily Id) are shown in Figures 2A and 3A , where, due to very low hydrolysis ( Figure 3A for ppGalNAc-T4, the lectin domain probing glycopeptide GP Table I . Catalytic and lectin domain probing random (glyco)peptide substrates a ppGalNAc-T catalytic domain probing substrates GP(T*10)C (green) GAGAXXXXXT* 10 XXXXXAGAG
Underlined X's indicate the presence of Ser or Thr acceptor sites. b The GPII glycopeptide used in prior studies contains 1 less X in each direction from the T* (Perrine et al. 2009) 2 Note however that the kinetic studies of Raman et al. 2008 ) also report lectin domain involvement in product release for an N-terminal T* glycosylated MUC5AC-3 glycopeptide substrate. This explains the observation that the lectin domain of T2 can also direct remote glycosylation C-terminal of a T* with certain substrates. The molecular mechanisms of how the lectin domain-mediated product release occurs and contributes to the T2's C-terminal long-range glycopeptide specificity is presently unknown and awaits further study.
(T*10)L is the most favorable substrate, showing the highest GalNAc incorporation (see Figure 3B right panel, blue series). For the remaining "glycopeptide-preferring" family II transferases, variable incorporation into the lectin probing substrates GP(T*22)R and GP(T*10) L, is observed ( Figure 3C -E), with the exceptions of the fly PGANT7 which shows substantial and nearly equal incorporation into GP(T*22)R and GP(T*10)L ( Figure 3F ). Also shown in Figures 2 and 3 are the plots for the control nonglycosylated peptide substrates GP(A22)R and GP(A10)L ( pink and turquoise series, respectively) which show reduced activities and little transfer to peptide compared with their glycosylated analogues. This suggests that for the "glycopeptide-preferring" transferases, the lectin domain plays variable roles in remote glycopeptide site selection, ranging from very high for ppGalNAc-T4 and PGANT7 and essentially none for ppGalNAc-T10.
To further quantify and compare each transferase substrate preference, we determined the percent (or efficiency) of GalNAc transferred to substrate (relative to total UDP-GalNAc utilization) from the gel filtration plots shown in Figure 3 for GP(T*22)R, GP(T*10)L and GP (T*10)C. These data are plotted in Figure 4 which clearly shows that the efficiency of transfer varies depending on the glycopeptide substrate and ppGalNAc-T isoform family and subfamily. For the "peptide-preferring" subfamilies Ia-d, transfer is highest with glycopeptide substrates GP(T*22)R and GP(T*10)L (60-90%), while a much lower percentage of transfer (3-20%) is observed for GP (T*10)C. By comparison, the "glycopeptide-preferring" transferases in subfamilies IIa-b, generally show less transfer to GP(T*22)R and GP(T*10)L and greater transfer to GP(T*10)C compared with the family I transferases. Nonetheless, the subfamily IIa transferases, ppGalNAc-T4 and T12 show the highest percent transfer to GP (T*10)L (40-75%) while having substantial transfer to GP(T*10)C (30-35%). The more strict "glycopeptide-preferring" transferases in subfamily IIb, ppGalNAc-T7 and T10 have high transfers to GP (T*10)C (20-40%) and much lower (or almost no transfer) to GP (T*22)R and GP(T*10)L (3-30%). Interestingly, the fly PGANT7, which is in the same subfamily as ppGalNAc-T7 and T10, possesses very high transfers to all three substrates GP(T*10)C, GP(T*22)R and GP(T*10)L (50-70%).
Glycosylation site determination on GP(T*10)C Edman sequencing of the GP(T*10)C products of ppGalNAc-T2, T3, T4, T5, T7, T10, T12 and PGANT7 were performed to locate transferase specific glycosylation sites relative to the central Thr-O-GalNAc (T*). PTH derivatives at each cycle were counted for [ 3 H]-GalNAc incorporation and plotted in Figure 5A -H. 4 For clarity, diagrams indicating the sites of glycosylation on GP(T*10)C are shown in the right panels of Figure 5A -H, while for panels A-D diagrams representing the glycosylation of the lectin domain probing GP(T*22)R and GP (T*10)L are also shown below the GP(T*10)C notation. For the family I transferases, a peak of GalNAc incorporation is observed at the −5 position from the T* for ppGalNAc-T2 and T5, and at the +5 position for ppGalNAc-T3 (see Figure 5A -C). As discussed below, these remote +/−5 positions correlate with the lectin domain substrate preferences for these isoforms and may therefore reflect remote lectin domain interactions with the T* of GP(T*10)C. Note that these family I transferases show no peaks of [ 3 H]-GalNAc incorporation at X positions 1-4 residues adjacent to the T*suggesting that the catalytic domains of these transferases do not recognize T* and may indeed be sterically hindered by the presence of the T* (Gerken et al. 2002; Gerken 2004; Perrine et al. 2009 ). Interestingly, for ppGalNAc-T2 we observe very low [ 3 H]-GalNAc incorporation spread across the −4 to −1 positions with a comparatively small peak at the +4 position. The [ 3 H]-GalNAc incorporation at these positions is not thought to be entirely due to sequencing lag, since similar positions were shown to be weakly glycosylated in our previous studies with ppGalNAc-T2 on a similar glycopeptide, GPII (Perrine et al. 2009 ), thus T2 may have a very limited ability to glycosylate directly near a prior site of glycosylation. ppGalNAc-T4 displays a completely different behavior with the GP(T*10)C substrate ( Figure 5D ), showing nearly equal incorporation at the +1 and +5 positions. This suggests that ppGalNAc-T4 prefers to glycosylate a Ser (or Thr) residue directly C-terminal to (+1) and five (+5) C-terminal positions away from a T* residue. It is likely that ppGalNAc-T4's +5 preference may be due to lectin domain interactions, consistent with its high preference for GP(T*10)L (right panel of Figure 5D ). These sites of glycosylation are consistent with ppGalNAc-T4's high activity against glycopeptides A2 and A4 5 of the glycopeptide library of Pratt and coworkers which possess a +1 and +5 acceptor site from a T* (Pratt et al. 2004 ).
ppGalNAc-T12, which belongs to the same subfamily as ppGalNAc-T4 (72% identity), shows maximum incorporation at the −3 position relative to T* ( Figure 5E ), indicating that T12 prefers to glycosylate a Ser (or Thr) residue three residues N-terminal from a Thr-O-GalNAc. ppGalNAc-T12 also glycosylates the −3 site on the GPII substrate (described in Perrine et al. 2009 ) (data not shown). In contrast to ppGalNAc-T4, ppGalNAc-T12 does not glycosylate the +5 position of GP(T*10)C which is consistent with its weaker activity against lectin probing GP(T*10)L.
Our previous studies with ppGalNAc-T10 on GPII have shown that it will glycosylate a Ser (or Thr) residue directly N-terminal (−1) of a Ser or Thr-O-GalNAc residue (Perrine et al. 2009 ). This is Fig. 4 . Efficiency of GalNAc transfer to acceptor glycopeptides varies with ppGalNAc-T family. Bars represent the percent (i.e. efficiency) of GalNAc transfer to the indicated glycopeptide substrates: GP(T*22)R, GP(T*10)L and GP(T*10)C respectively. Left grouping of bars represents the "peptide-preferring" subfamily I transferases, ppGalNAc-T1, T2, T3, T5, T13 and T16, while the right grouping of bars represents the "glycopeptide-preferring" subfamily II transferases ppGalNAc-T4, T12, T10, T7 and PGANT7. Values are obtained from 2 to 4 G10 gel filtration runs of standard overnight incubations (in Figure 3 and data not shown) and (Gerken et al. 2013) . Note that these values are displayed to reveal trends and may vary with the transferase reaction conditions. Error bars represent SD from 2 to 4 experiments. This figure is available in black and white in print and in color at Glycobiology online.
4 A noticeable feature for the plots is the sequencing lag in 3 H content following a peak of maximum incorporation. This is due to the lower solubility of the PTH-Ser-O-GalNAc derivative, compared with the standard amino acid PTH derivatives, in the organic solvents used to extract the sample filter during the Edman sequencing.
5 Glycosylation of A2 (PT*2TDSTTPAPTTKK) and A4 (PTTDST* TPAPTTKK) by ppGalNAc-T4 is observed at Thr-7 in both substrates. In A2, Thr-7 is five C-terminal positions (+5) from the T*2 and in A4 Thr-7 is one C-terminal (+1) position from the T*6. (Gerken et al. 2013) or from this work). All plots are for overnight incubations of GP(T*10)C with the indicated transferase and are representative of at least two sequence determinations. This figure is available in black and white in print and in color at Glycobiology online.
confirmed in the present study with GP(T*10)C (see Figure 5F ). ppGalNAc-T7, in the same subfamily as ppGalNAc-T10 shows identical behavior with the GP(T*10)C substrate, ( Figure 5G ) as does PGANT7 the fly orthologue to human T7 (Ten Bennett et al. 2012 ) ( Figure 5H ). It is noteworthy that these transferases do not exhibit the −5 or +5 preferences suggesting that little lectin domain involvement in glycosylating GP(T*10)C. Thus, with GP(T*10)C we have shown that both subfamilies of "glycopeptidepreferring" transferases studied to date glycosylate unique and specific neighboring sites on glycopeptide substrates. Because these sites are only 1-3 residues from the T* we conclude that this specificity must be due to T* binding in the substrate binding cleft of the catalytic domain of these transferases.
Comparison with nonglycosylated control GP(A10)C
To further confirm that the glycosylation site specificity observed with GP(T*10)C is due to the T* binding to the transferase's catalytic (or lectin) domain and not due to end effects, or any other artifact, we preformed glycosylation reactions using a subset of transferases against both GP(T*10)C and GP(A10)C, where in the latter substrate the central T* was replaced by an Ala residue. Due to limited transferase availability, reactions were performed using ppGalNAc-T2, T4 and T10 representing subfamily I, IIa and IIb, respectively. Their gel filtration and Edman sequencing plots are shown in Figure 6A -C (right and left panels, respectively). The gel filtration plots show that ppGalNAc-T2 transfers slightly more [ 3 H]-GalNAc to GP(A10)C than GP(T*10)C, while with ppGalNAc-T4 and T10, transfer to GP (T*10)C is significantly greater than to the control GP(A10)C which is very low. As expected, the Edman sequencing of the GP(A10)C products of ppGalNAc-T4 and T10 ( Figure 6B and C) displays very low incorporation plots and shows no specific peaks of glycosylation which is in contrast to what is observed with GP(T*10)C (see Figure 5D and F). These results clearly confirm the glycopeptide requiring activity of these transferases, where a prior T* (or S*) must be within 1 to ∼4 residues of the acceptor site. On the other hand, with ppGalNAc-T2, a neighboring T* (or S*) is nearly inhibitory, thus only the remote flanking −5 site is glycosylated in GP(T*10)C (see Figure 5A ), which is likely lectin domain mediated. Therefore, the ppGalNAc-T2 glycosylation of GP(A10)C, which does not contain the inhibiting T*, gives a broad peak of [ 3 H]-GalNAc incorporation with a maximum observed directly N-terminal to the center Ala ( Figure 6A ). These results clearly indicate that ppGalNAc-T2's Figure 5A , D and F. These plots are determined from a single experimental run for each transferase. This figure is available in black and white in print and in color at Glycobiology online.
catalytic domain can only readily glycosylate nonglycosylated "naked" peptide substrates.
Lectin domain-mediated glycosylation site determination
As performed previously for the family I ppGalNAc-T's (Gerken et al. 2013) , Edman amino acid sequencing of the GP(T*22)R and GP (T*10)L products glycosylated by ppGalNAc-T4, T7, T12 and PGANT7 were performed to determine the optimal distance between the lectin bound T* and the [ 3 H]-GalNAc glycosylated X residues.
These plots are shown in Figure 7 . Unlike the plots for GP(T*10)C, these plots show a broad distribution of maximum incorporation for the preferred substrate for ppGalNAc-T4, T12 and PGANT7. ppGalNAc-T7 which shows low incorporation into both GP(T*22)R and GP(T*10)L, gave undetectable incorporation while the products of ppGalNAc-T10 were not analyzed due to even lower incorporation. As previously shown in Figures 3 and 4 , both ppGalNAc-T4 and T12 have high transfer to GP(T*10)L and show broad peaks of incorporation in Figure 7A and B. As discussed above, we observe a +5 preference for ppGalNAc-T4 which is not observed for T12 when glycosylating GP(T*10)C ( Figure 5D ]-GalNAc incorporation plot could be easily extrapolated to the +5 position while T12's plot would not). This suggests that lectin domain-mediated glycosylation for ppGalNAc-T4 begins at the +5 residue while the weaker lectin domain-mediated glycosylation of ppGalNAc-T12 begins at (or after) the +6 residue. Therefore, using the two different glycopeptides, we have obtained consistent data showing that there are differences between the lectin domains of these two ppGalNAc-T's. We have summarized these results in cartoon form against the ppGalNAc-T family phylogenetic tree in Figure 8 .
The shapes of the distribution of [ 3 H]-incorporation into GP (T*22)R and GP(T*10)L by PGANT7 ( Figure 7D ) suggest that maximum glycosylation may be more distant from the T* for both GP (T*22)R and GP(T*10)L which is consistent with PGANT7 not glycosylating −5/+5 positions of GP(T*10)C. 
Discussion
In this work, we have extended our prior studies of the "peptidepreferring" family I, transferases ( ppGalNAc-T1, T2, T3, T5, T6, T13, T14 and T16) to members of the "glycopeptide-preferring" family II, transferases (ppGalNAc-T4, T7, T10, T12 and PGANT7) using our series of lectin domain probing glycopeptide substrates (Table I and Figures 2 and 3 ). In addition, we have introduced a new glycopeptide substrate, GP(T*10)C (Table I) , to address the role of directly neighboring glycosylation and to reveal specific sites of glycosylation catalyzed by the catalytic domain ( Figure 5 ). Using these glycopeptide substrates, the roles of the catalytic and lectin domains in glycosylating glycopeptide substrates can be systematically characterized in terms of neighboring (1-5 residues) and remote (6-17 residues) prior glycosylation.
We have found that 4 of the 5 "glycopeptide-preferring" family II transferases have elevated activities towards GP(T*10)C and that each glycosylates unique sites on this substrate. This suggests that the Fig. 8 . Correlation of glycopeptide specificities with the ppGalNAc-T phylogenetic family tree. To the right of the ppGalNAc-T subfamily phylogenetic tree ) are plotted the glycopeptide preferences obtained from this work and previous work (Gerken et al. 2013) . Glycopeptide substrate cartoons representing GP(T*22)R (left column), GP(T*10)L (middle column) and GP(T*10)C (right column) are shown where the T* represents the position of the initial Ser/Thr-O-GalNAc while the arrows indicate the position(s) glycosylated by the indicated transferase isoform. Note for GP(T*22)R and GP(T*10)L the arrows represent a broad distribution of glycosylation. Substrates with low or no activities are marked with a thin black line. Transferases whose preferences have not been determined against these substrates are left as a blank space. GP(T*10)C cartoons having arrows with parenthesis represent the proposed +/−5 lectin domain-mediated glycosylation site preference. This figure is available in black and white in print and in color at Glycobiology online.
binding of the Thr-O-GalNAc residue of GP(T*10)C at specific sites in the catalytic domain directs subsequent neighboring site selection in these transferases. We have also observed that the lectin domain probing glycopeptides, GP(T*22)R and GP(T*10)L, show variable activities with the "glycopeptide-preferring" transferases; hence, the involvement of the lectin domain in directing remote glycosylation for these transferases ranges from nearly none to relatively high depending on isoform.
In contrast, the "peptide-preferring" family I transferases characterized to date show the greatest activity for one or both of the lectin domain probing glycopeptides, indicating that Thr-O-GalNAc binding at the lectin domain directs and enhances remote glycosylation. The "peptide-preferring" transferases all have very low activities against the catalytic domain probing glycopeptide, GP(T*10)C, and do not glycosylate directly neighboring (1-4) sites, strongly suggesting that there are no Ser/Thr-O-GalNAc-binding sites in the catalytic domain of these transferases.
These results demonstrate that there are at least two different modes of glycopeptide substrate recognition by the ppGalNAc-Ts. These would be the recognition of a glycopeptide GalNAc at the lectin domain, directing remote glycosylation to the catalytic domain ( Figure 9A ) and the direct binding of glycopeptide GalNAc within the catalytic domain, targeting specific neighboring glycosylation ( Figure 9B ). We shall refer to these activities as lectin domain assisted and catalytic domain directed which can operate singly or together depending on the isoform.
We would also like to address the overlapping peptide/glycopeptide substrate preferences for the different transferase isoforms and suggest renaming of the classifications of family I and family II transferases. Since subfamily Ia-d members have elevated activities against glycopeptide substrates with a remote prior glycosylation site and thus not strictly peptide-preferring transferases, we suggest that for clarity, these family Ia-d members be reclassified as remote glycopeptide/peptide-preferring isoforms (abbreviated as remote GP/P-preferring). Similarly, the subfamily IIa members have been shown to be relatively active towards a number of nonglycosylated peptide substrates and therefore not strictly glycopeptide-preferring transferases, we suggest that the subfamily IIa members be termed mixed (glyco)peptide-preferring isoforms (abbreviated as mixed (G)P-preferring). Since subfamily IIb members are poorly active towards naked peptide substrates, we suggest calling them strict glycopeptide-preferring isoforms (abbreviated as strict GP-preferring).
Mixed (Glyco)peptide-preferring transferases ppGalNAc-T4 and T12 (subfamily IIa)
Previous work on ppGalNAc-T4 has shown it to be highly active against Ser/Thr-O-GalNAc glycosylated substrates and that its lectin domain is required for this activity (Hassan et al. 2000; Wandall et al. 2007 ). With our catalytic and lectin domain probing substrates, we have presented data that strongly suggests that ppGalNAc-T4 glycopeptide glycosylation is directed by both its catalytic and lectin domains depending on the distance between the acceptor sties and the existing Ser/Thr-O-GalNAc. Thus the catalytic domain of ppGalNAc-T4 directs glycosylation to one residue (+1) C-terminal of an existing T* while its lectin domain assists in directing glycosylation from +5 to over +13 residues C-terminal from the T*. Interestingly, ppGalNAc-T4 displays the highest lectin domain activity (against GP(T*10)L) of all the "glycopeptide-preferring" family II members studied, perhaps explaining prior conclusions that its lectin domain was solely responsible for the glycopeptide activity.
ppGalNAc-T12 is 72% identical to ppGalNAc-T4 and also utilizes its catalytic and lectin domains to recognize and glycosylate (upper panel ppGalNAc-T1, T2, T5,  T13, T14, T16 and PGANT7, lower panel ppGalNAcT3, T4, T5, T6, T12, T13, T16 and PAGANT7). (B) Catalytic domain glycopeptide recognition (i.e. the catalyticdomain directed property) by the mixed (glyco)peptide-preferring subfamily IIa transferases (ppGalNAc-T4 and T12) and the strict glycopeptide-preferring subfamily IIb (ppGalNAc-T7, T10 and fly PGANT7). (C) Peptide substrate binding to the catalytic domain directing glycosylation by the remote glycopeptide/ peptide-preferring subfamilies Ia-Id (ppGalNAc-T1, T2, T3, T5, T6, T13, T14 and T16) and mixed (glyco)peptide-preferring subfamily IIa (ppGalNAc-T4 and T12). The large gray oval represents the catalytic domain while the smaller right or left tethered ovals represent the lectin domain and the thick black line represents (glyco)peptide acceptor (see Discussion for an explanation of the renamed family/subfamily classifications). This figure is available in black and white in print and in color at Glycobiology online.
Ser/Thr-O-GalNAc containing glycopeptides. In spite of its highsequence conservation to ppGalNAc-T4, its catalytic domain glycosylates three residues (−3) N-terminal from an existing T* while its lectin domain assists in directing glycosylation from +6 to over +13 residues C-terminal from a T*. ppGalNAc-T4 and T12 therefore serve the socalled glycopeptide filling-in roles whose actual specificities had been unknown until this study. In keeping with this activity, both transferases are highly expressed in tissues that produce densely glycosylated mucin glycoproteins (Young et al. 2003) .
Our previous studies on ppGalNAc-T12 revealed that it also has good activities towards nonglycosylated random peptide substrates showing the "classical" ppGalNAc-T preferences for Pro at the +1 and +3 positions relative the site of glycosylation (Gerken et al. 2011) and possessing the conserved aromatic residue motifs that have been linked to this specificity as shown in Supplementary material, Figure S1 (Gerken et al. 2011; Lira-Navarrete et al. 2015) . This aromatic residue motif is also conserved in ppGalNAc-T4 6 but not in ppGalNAc-T7, T10 or PGANT7 further confirming that ppGalNAc-T4 and T12 have mixed roles serving to glycosylate both peptide and glycopeptide substrates.
Strict glycopeptide-preferring transferases ppGalNAc-T7, T10 and PGANT7 (subfamily IIb)
ppGalNAc-T7 and T10 possess 48% sequence identity and will both glycosylate one residue N-terminal (−1) of a prior site of glycosylation which is highly suggestive of a catalytic domain-directed activity. The lectin domain-assisted glycosylation for these transferases is very low in contrast to the subfamily IIa mixed (glyco)peptide-preferring transferases. Therefore, the removal of the lectin domain of ppGalNAc-T10 is found to only slightly alter its long-range glycosylation specificity against glycosylated substrates but it does not affect its ability to glycosylate at the −1 position relative to a T* (Raman et al. 2008) . We have previously shown (utilizing additional random (glyco)peptides not described here) that ppGalNAc-T10 is highly selective for glycosylating directly N-terminal (−1) of an S* or T*, but nevertheless can only very poorly glycosylate nonglycosylated random peptides (Perrine et al. 2009 ) and lacks the "classical," (T/S)PXP, Pro-binding motifs as does ppGalNAc-T7. 7 Therefore, ppGalNAc-T10 and T7
likely possess nearly identical specificities and serve primarily to function as strict filling-in transferases, glycosylating directly N-terminal of an existing S* or T*. This is again in keeping with their high expression in tissues that produce densely glycosylated mucins (Young et al. 2003) . The Drosophila PGANT7 is classified in the same IIb subfamily with other mammalian GALNT genes ) and shares a 41% sequence identity with ppGalNAc-T7. Unsurprisingly, PGANT7 displays the identical catalytic domain-directed strict requirement for an N-terminal (−1) glycosylation site relative to T* that is observed for ppGalNAc-T7 and T10. In contrast to ppGalNAc-T7 and T10, PGANT7 will nearly equally glycosylate remote sites from 6 to ∼13 residues N-or C-terminal from a T*, indicating that PGANT7 possesses the ability for long-range glycosylation that must be mediated by its lectin domain. Thus, PGANT7 possesses both strong catalytic domain-directed and lectin domain-assisted activities, with the latter activity lacking in its mammalian orthologues. Whether PGANT7 (which also lacks the "classical" Pro-binding motifs) can glycosylate nonglycosylated peptides is presently unknown.
Correlation of lectin domain binding preference with transferase sequence
In our previous work, we attempted to determine whether any linker or lectin domain motifs might relate to a transferase's remote glycopeptide N-or C-directional preference by aligning their linker and lectin domains (Gerken et al. 2013 ). As we have previously observed for the family I transferases, the linker domains within the subfamily IIa or IIb transferases do not reveal any obvious differences in sequence or length that can account for the differences in their remote lectin domain-assisted glycosylation behavior (see Supplementary material, Table SI ). Indeed, the PGANT7 linker shows the greatest similarity to the ppGalNAc-T10 linker, compared with ppGalNAc-T7, despite the fact that PGANT7 and T10 have significantly different lectin domain-assisted activities. It is also worth noting that the mixed (glyco)peptide-substrate ppGalNAc-T4 and T12 (subfamily IIa) linkers appear to be more similar to the remote glycopeptide/peptide class I linkers than to the more strict glycopeptide-preferring subfamily IIb linkers which are all ∼5 residues longer.
Several studies of the ricin lectin α, β and γ-subdomains in multiple species, from bacteria to mammals, have revealed a number of sugar binding sequence motifs, the most common being the CLD and QXW sequences (Hazes 1996; Imberty et al. 1997; Fujimoto et al. 2000; Maveyraud et al. 2009) . Mutagenesis studies have shown that the Asp residue of the CLD motif is typically required for lectin-binding activity (see Figure 1B) . These motifs are variously found in the lectin domains of the ppGalNAc-Ts where mutational and structural studies have revealed that only specific lectin subdomains may actively bind GalNAc (Hassan et al. 2000; Tenno et al. 2002; Fritz et al. 2004; Pratt et al. 2004; Kubota et al. 2006; Wandall et al. 2007; Pederson et al. 2011) .
In our previous work on the family I transferases, we found no obvious correlation in the ricin domain motifs and the transferase's glycopeptide directional preferences (Gerken et al. 2013 ) and come to the same conclusion with the family II transferases characterized in this work (see Supplementary material, Table SI ). In fact, we may again observe an inverse correlation between the mammalian ppGalNAc-T7, T10 and the fly PGANT7. For ppGalNAc-T10 all three lectin subdomains possess likely binding motifs and its X-ray structure shows Ser-O-GalNAc bound to its β-subdomain (Kubota et al. 2006) . However, no significant activity is observed with our lectin domain probing substrates. Likewise, ppGalNAc-T7 has only one canonical lectin motif, the γ-subdomain, and it shows little activity with either of our lectin domain substrates. In contrast, PGANT7 contains no truly canonical motifs (its α-subdomain having the closest: CLD-QLV) but displays highly significant activities against both lectin domain probing glycopeptides. Since PGANT7 displays clear long-range glycopeptide specificities, at least one of its lectin subdomains must possess significant, although weak, binding activity to account for its long-range glycopeptide specificity.
Such weak lectin binding is consistent with prior studies on the ppGalNAc-Ts, as direct glycopeptide binding to any of the ppGalNAc-Ts lectin domains, regardless of motif, cannot be readily detected (Wandall et al. 2007; Pederson et al. 2011; Yoshimura et al. 2012) , confirming the weak binding nature of the ppGalNAc-T lectin domains. This is sensible, since tight lectin binding of 6 Preliminary studies on random peptide substrates show that ppGalNAc-T4 possesses the same TPXP substrate preference motif (data not shown). 7 Preliminary random peptide studies also suggest similar behavior for ppGalNAc-T7 which also lacks the Pro residue sequence recognition motif (data not shown).
glycopeptide substrates would likely be nonproductive, slowing glycosylation due to delayed product release. As we discussed earlier (Gerken et al. 2013) , lectin domain binding may simply increase the local concentrations of substrate while orientating it in the catalytic domain cleft. Clearly, further detailed structural studies are needed to begin to understand the roles of the lectin domains in these transferases. The recently reported X-ray crystal structures, small angle X-ray scattering and solution modeling studies of ppGalNAc-T2 interacting with MUC5AC glycopeptides is an important step in this direction (LiraNavarrete et al. 2015) confirming the dynamic flexibility between the ppGalNAc-T2 catalytic and lectin domains (Gerken et al. 2013 ).
UDP-GalNAc hydrolysis
In our studies of the ppGalNAc-T's, we observed variable nonproductive hydrolysis of the UDP-[ 3 H]-GalNAc donor (i.e. transfer to water) vs. transfer to peptide/glycopeptide substrate. Presently, we do not know what factors are involved but there is clearly competition with transfer of GalNAc to water and transfer to substrate. Interestingly, the family I "peptide-preferring" and family II "glycopeptidepreferring" transferases behave very differently, where the lowest hydrolysis is found with their preferred substrates. Thus, the rate of nonproductive hydrolysis may be a measure of how well an acceptor substrate productively binds to the active site of the catalytic domain.
Potential limitations
The random glycopeptide substrates utilized in these studies are relatively short and contain a relatively high content of Gly and Pro compared to most proteins, hence these are expected to possess extended random structures that cannot fully represent the complexity of a folded protein. We recognize that this may be a limitation to our methods, particularly since previous work has shown that ppGalNAc-T11 recognizes the tertiary structure of the linker regions of the LDLR receptor (Pedersen et al. 2014) . Nevertheless, these (glyco)peptide substrates have provided highly useful and previously not understood data that has helped us more fully understand the unique roles of the catalytic and lectin domains of these transferases. These data will be substantially useful in future studies of the ppGalNAc-T against both folded and extended proteins and peptides.
Conclusion
With these studies, a clearer understanding the functions of the lectin and catalytic domains in modulating glycopeptide substrate specificity has been revealed. For example, we can distinguish between the effects of neighboring (+/−5 residues) prior glycosylation, due to glycopeptide binding at the catalytic domain, to the longer range effects of remote glycosylation (+/−6 to 17 residues), where glycopeptide binding is mediated by the lectin domain (Figure 8 ). Of particular interest, we have observed clear and unexpected differences in activity and directionality among the transferases studied to date. For the first time, we have identified multiple catalytic domain GalNAc-binding sites for the "glycopeptide-preferring" transferases in subfamilies IIa and IIb that likely account for their glycopeptidespecific activities. These transferases are commonly called filling-in transferases and in this work we now have identified site preferences for their respective activities. We have also observed that for the "peptide-preferring" (i.e. remote GP/P-preferring) family I, transferases that the lectin domain is nearly always involved in remote glycosylation of glycopeptides and that this may be modulated in an N-or C-terminal direction. This lectin domain involvement is only variably observed for the "glycopeptide"-preferring family II transferases.
We have further demonstrated the partial conservation of specificity between the fly and human orthologues PGANT7 and ppGalNAc-T7, which display identical catalytic domain-directed glycopeptide specificities, but quite different remote lectin domain glycopeptide specificities.
With these studies, we now have a better understanding perhaps why this large family of transferases exists. Each isoform contains a unique combination of catalytic domain-directed (glyco)peptide specificity and lectin domain remote glycopeptide specificity. Thus, for example, the isoforms in the Ia ( ppGalNAc-T1 and T13) and Ib ( ppGalNAc-T2, T14, T16) subfamilies of remote GP/P-preferring transferases all have nearly indistinguishable random peptide sequence preferences (Gerken et al. 2011) 8 but possess different lectin domain preferences (Gerken et al. 2013) . Furthermore, the fact that nearly all ppGalNAc-T isoforms recognize either prior neighboring glycosylation or prior remote glycosylation, or a combination of both, suggests that these transferases must operate in an ordered process to perform their glycosylation functions, where one transferase produces an optimal glycopeptide substrate for its self or another transferase. Importantly, experimental evidence indeed exists suggesting an ordered process for ppGalNAc-T glycosylation (Iida et al. 2000; Kato et al. 2001; Nordén et al. 2015) . This suggests that mucintype O-glycosylation is potentially highly orchestrated in a cell and helps to further explain why the patterns of ppGalNAc-T isoform expression varies from cell type to cell type ). Thus, the over expression or suppression of a single transferase in this cascade could lead to multiple downstream alterations of subsequent glycosylation. The ultimate goals of our work are, therefore, to fully understand the properties of these transferases so that fully predictive models of mucin-type O-glycosylation can be developed.
Materials and methods
Reagents and random peptide substrates
All the random (glyco)peptide substrates listed in Table I (Gerken et al. 2013) were custom synthesized by Sussex Research, Ottawa, ON (Canada). Note that GP(T*22)R, GP(A22)R, GP(T*10)L and GP(A10)L were previously named GPIV, GPIV-Cont, GPV and GPV-Cont (Gerken et al. 2013) . Stock solutions of 50 mg/mL (15-17 mM) of random (glyco)peptide substrates were prepared by lyophilizing from water several times and adjusting to pH 7-7.5 with dilute NaOH/HCl. Fully N-acetylated UDP-[ 3 H]-GalNAc was purchased from American Radiolabeled Chemicals Inc. Dowex 1 × 8 anion exchange resin (100-200 mesh) was purchased from Acros Organics and Sephadex G10 was obtained from Amersham Biosciences and GE Healthcare. Edman amino acid sequencing was performed on an Applied Biosystems Procise 494 peptide sequencer as previously described (Gerken et al. 2006 (Gerken et al. ,2011 Perrine et al. 2009 ). Liquid scintillation counting was performed using a Beckman Model LS650.
Transferases
As in our previous work (Gerken et al. 2013) , ppGalNAc-T's were obtained from multiple sources and multiple expression systems as N-terminal truncated and affinity tagged constructs. They were used 
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